Charles River Laboratories International, Inc. (CRL)
298.58
+3.39
(+1.15%)
USD |
NYSE |
Aug 24, 16:00
298.74
+0.16
(+0.05%)
Pre-Market: 20:00
Charles River Laboratories International Total Assets (Quarterly) : 7.532B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.532B |
| March 31, 2026 | 7.730B |
| December 31, 2025 | 7.135B |
| September 30, 2025 | 7.514B |
| June 30, 2025 | 7.561B |
| March 31, 2025 | 7.582B |
| December 31, 2024 | 7.528B |
| September 30, 2024 | 8.004B |
| June 30, 2024 | 7.948B |
| March 31, 2024 | 8.153B |
| December 31, 2023 | 8.195B |
| September 30, 2023 | 7.607B |
| June 30, 2023 | 7.772B |
| March 31, 2023 | 7.699B |
| December 31, 2022 | 7.603B |
| September 30, 2022 | 7.383B |
| June 30, 2022 | 7.529B |
| March 31, 2022 | 7.075B |
| December 31, 2021 | 7.024B |
| September 30, 2021 | 7.058B |
| June 30, 2021 | 6.720B |
| March 31, 2021 | 5.809B |
| December 31, 2020 | 5.491B |
| September 30, 2020 | 5.213B |
| June 30, 2020 | 5.241B |
| Date | Value |
|---|---|
| March 31, 2020 | 5.202B |
| December 31, 2019 | 4.693B |
| September 30, 2019 | 4.583B |
| June 30, 2019 | 4.625B |
| March 31, 2019 | 3.927B |
| December 31, 2018 | 3.856B |
| September 30, 2018 | 3.797B |
| June 30, 2018 | 3.866B |
| March 31, 2018 | 3.001B |
| December 31, 2017 | 2.930B |
| September 30, 2017 | 2.866B |
| June 30, 2017 | 2.774B |
| March 31, 2017 | 2.697B |
| December 31, 2016 | 2.712B |
| September 30, 2016 | 2.690B |
| June 30, 2016 | 2.763B |
| March 31, 2016 | 2.104B |
| December 31, 2015 | 2.068B |
| September 30, 2015 | 2.033B |
| June 30, 2015 | 1.886B |
| March 31, 2015 | 1.847B |
| December 31, 2014 | 1.885B |
| September 30, 2014 | 1.842B |
| June 30, 2014 | 1.863B |
| March 31, 2014 | 1.652B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 29.88B |
| Medpace Holdings, Inc. | 2.057B |
| Fortrea Holdings, Inc. | 2.715B |
| Avantor, Inc. | 11.60B |
| Champions Oncology, Inc. | 26.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.644B |
| Shareholders Equity (Quarterly) | 2.840B |
| Debt to Equity Ratio | 1.069 |
| Current Ratio | 1.348 |
| Net Debt Paydown Yield | -0.08% |